|

TTX-080 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Tizona Therapeutics, Inc1

Indications

  • Lung Cancer1
  • Breast Cancer1
  • Cancer1

Tucson, Arizona1 trial

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Arizona Oncology Associates

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.